Invention Grant
- Patent Title: Inducible caspases and methods for use
-
Application No.: US16339710Application Date: 2017-10-06
-
Publication No.: US11377480B2Publication Date: 2022-07-05
- Inventor: Eric M. Ostertag , Devon Shedlock
- Applicant: Poseida Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Poseida Therapeutics, Inc.
- Current Assignee: Poseida Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Matthew Pavao
- International Application: PCT/US2017/055661 WO 20171006
- International Announcement: WO2018/068022 WO 20180412
- Main IPC: C07K14/47
- IPC: C07K14/47 ; C07K14/705 ; A61P37/00 ; A61P31/00 ; A61P3/00 ; A61P17/02 ; A61P29/00 ; A61P35/00 ; A61K35/17 ; C12N5/0783 ; C12N9/50 ; C12N15/52

Abstract:
The disclosure provides inducible caspase polypeptides, compositions comprising inducible caspase polypeptides and sequences encoding the same, cells modified to express the polypeptides and compositions of the disclosure, as well as methods of making and methods of using same for adoptive cell therapy.
Public/Granted literature
- US20190225667A1 INDUCIBLE CASPASES AND METHODS FOR USE Public/Granted day:2019-07-25
Information query